Featured at Biotherapeutics Analytical Summit:Core Principles and Best Practices for Biotech Analytical Test Methods across the Product LifecycleMarch 13-14, 2018Instructor: Nadine Ritter, PhD, Principal Consultant, Global Biotech Experts, LLC

Regulatory Requirements across the Product Development LifecycleMarch 15-16, 2018Instructor: Christine Vessely, PhD, Senior Consultant, Biologics Consulting Group

Featured at PEGS:Introduction to Protein Engineering April 30-May 1, 2018 | Boston, MADavid Bramhill, PhD, Founder, Bramhill Biological Consulting, LLC

Introduction to Structure-Based Drug Design and Development April 30-May 1, 2018 | Boston, MA Christopher Corbeil, PhD, Research Officer, Human Health Therapeutics, National Research Council Canada

Traian Sulea, PhD, Senior Research Officer, Human Health Therapeutics, National Research Council Canada

Introduction to BioprocessingApril 30-May 1, 2018 | Boston, MASheila G. Magil, PhD, Senior Consultant, BioProcess Technology Consultants, Inc.

Frank J. Riske, PhD, Senior Consultant, BioProcess Technology Consultants, Inc.

Introduction to Design of Experiments for Bioassay Development April 30-May 1, 2018 | Boston, MAPerceval Sondag, Senior Manager, Statistics, PharmaLex

Next Generation Sequencing for Antibody Discovery and EngineeringMay 2-3, 2018 | Boston, MASimon Friedensohn, MSc, Research Assistant; Biosystems Science and Engineering, ETH Zurich, Switzerland

Enkelejda Miho, PhD, Research Assistant II, Biosystems Science and Engineering; Pioneer Innovation & Entrepreneurship Lab, ETH Zürich, Switzerland

Healthtech.com/training-seminars

By Cambridge Healthtech Institute

Continued on reverse side …

Cambridge Healthtech Institute Training Seminars offer real-life case studies, problems encountered and solutions applied, along with extensive coverage of the academic theory and background. Each training seminar offers a mix of formal lecture and interactive discussions and activities to maximize the learning experience. These training seminars are led by experienced instructors who will focus on content applicable to your current research and provide important guidance those new to their fields.

CambridgeHealthtech InstituteOrganized by

Immunology for Drug Discovery ScientistsMay 2-3, 2018 | Boston, MAMasha Fridkis-Hareli, MSc, PhD, Founder and President, ATR, LLC

Tatiana Novobrantseva, PhD, Co-Founder, Head of Research and Development, Verseau Therapeutics

Introduction to ImmunogenicityMay 3-4, 2018 | Boston, MAArno Kromminga. PhD, Senior Vice President and European Chief Scientific Officer, BioAgilytix

Featured at World Preclinical Congress:Introductory Immunology for Autoimmune and Cancer Drug DiscoveryJune 19-20, 2018 | Boston, MATim Bauler, PhD, Assistant Professor, Department of Biomedical Sciences, Western Michigan University Homer Stryker M.D. School of Medicine

Tom Sundberg, PhD, Senior Research Scientist I, Center for the Development of Therapeutics, Broad Institute of MIT and Harvard

Applying Pharmacology to New Drug Discovery: The System-Independent Quantification of Molecular Drug Properties for Prediction of Therapeutic UtilityJune 19-20, 2018 | Boston, MATerry Kenakin, PhD, Professor, Department of Pharmacology, University of North Carolina School of Medicine

Genome Editing with Targeted Nucleases: Theory and Practice of CRISPR/Cas9 Technology Applications from Basic Research to Precision TherapiesJune 19-20, 2018 | Boston, MASerguei Kozlov, PhD, MBA, PMP, Principal Scientist/PM, Team Leader PTO, Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research (NCI)

Danilo Maddalo, PhD, Lab Head, ONC Pharmacology, Novartis Institutes for BioMedical Research, Novartis Pharma AG

Practical Introduction to PKPD Modeling in Drug Discovery and Development: Better, Faster, CheaperJune 20-21, 2018 | Boston, MA Arijit Chakravarty, CEO, Fractal Therapeutics

Ryan Nolan, PhD, Research Fellow, Takeda Pharmaceuticals International Co

Introduction to Small Molecule Drug Discovery and DevelopmentJune 20-21, 2018 | Boston, MA H. James Harwood Jr., PhD, Founder and CEO, Delphi BioMedical Consultants, LLC

Patient-Derived ASC-Organoids for Drug Development and Screening, Patient Stratification and Regenerative MedicineJune 20-21, 2018 | Boston, MASylvia F. Boj, PhD, Scientific Director, Hubrecht Organoid Technology

Each CHI Training Seminar offers 1.5 Days of instruction with start and stop times for each day shown above and on the Event-at-a-Glance published in the onsite Program & Event Guide. Training Seminars will include morning and afternoon refreshment breaks, as applicable, and lunch will be provided to all registered attendees on the full day of the class.

Each person registered specifically for the training seminar will be provided with a hard copy handbook for the seminar in which they are registered. A limited number of additional handbooks will be available for other delegates who wish to attend the seminar, but after these have been distributed no additional books will be available.

Though CHI encourages track hopping between conference programs, we ask that Training Seminars not be disturbed once they have begun. In the interest of maintaining the highest quality learning environment for Training Seminar attendees, and because Seminars are conducted differently than conference programming, we ask that attendees commit to attending the entire program, and NOT engaging in track hopping, as to not disturb the hands-on style instruction being offered to the other participants.

By Cambridge Healthtech Institute

For detailed agendas, additional training seminars and more information, please contact Dan Miller at DMiller@healthtech.com

or visit Healthtech.com/training-seminars.

Continued from reverse side …